360Dx34m
Accelerate Diagnostics Submits Wave Platform and Gram-Negative Test to FDA
The company also reported that its fourth quarter revenues dropped 7 percent from a year ago, while full-year 2024 revenues declined 3 percent.
C&EN3d
Treatment of Acute Liver Injury through Selective Tropism of High Mobility Group Box 1 Gene-Silenced Large Peritoneal Macrophages
Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Northeastern University, 360 Huntington Avenue, Boston, Massachusetts 02115, United States Alnylam ...